Pharma Pulse: Disruptions and Innovations in the Pharmaceutical Industry
This episode of Pharma Pulse covers key developments in the pharmaceutical industry, including Mark Cuban's direct-to-consumer pharmacy challenging traditional drug pricing models.
- Mark Cuban's pharmacy is disrupting the prescription drug market.
- AstraZeneca is investing $4.5 billion to expand its Virginia manufacturing site.
- Bristol Myers Squibb has acquired Orbital Therapeutics for $1.5 billion to advance RNA-based medicines.
These developments reflect a fast-evolving landscape for pharma strategy and patient access, focusing on cost transparency, domestic manufacturing, and next-generation RNA innovation.
From cost transparency and domestic manufacturing to next-generation RNA innovation, these developments reflect a fast-evolving landscape for pharma strategy and patient access.
Author's summary: Mark Cuban disrupts drug pricing with his pharmacy.
More News
- Jonathan Taylor explodes for Colts, fantasy owners, beat Falcons in overtime
- Highlights and goals: Dundee 0-3 Rangers in Scottish Premiership | 11/09/2025
- Pakistan beat Kuwait to clinch Hong Kong Sixes 2025 trophy
- Arc Raiders breaks another concurrent record as player count soars
- Pakistan beat Kuwait to win Hong Kong title - Daily Times
- Colts' Jonathan Taylor's insane statline against Falcons hasn't been done since Le'Veon Bell | Sporting News
- Dundee 0-3 Rangers: That's Moore like it as Rohl's men gather momentum
- Dune: Awakening Revives the Communinet Signal With Fresh News on Merges and Twitch Drops | MMORPG.com